What is Hormone Therapy Before Micro-TESE?
Azoospermia is defined as the complete absence of sperm in the ejaculate. In non-obstructive azoospermia (NOA), sperm production in the testes is either severely impaired or absent. Hormone therapy administered prior to Micro-TESE (Microsurgical Testicular Sperm Extraction) aims to optimize the intratesticular microenvironment, stimulate spermatogenesis, and maximize the probability of retrieving viable sperm during the surgical procedure.
The Importance of Hormonal Evaluation and Target Hormones
Before initiating therapy, a detailed endocrine profile of the patient is analyzed. The status of the hypothalamic-pituitary-testicular axis, which regulates sperm production, is evaluated. The key hormones monitored during this process include:
- FSH (Follicle-Stimulating Hormone): Stimulates Sertoli cells in the testes to initiate spermatogenesis.
- LH (Luteinizing Hormone): Stimulates Leydig cells to produce testosterone.
- Total Testosterone: Intratesticular testosterone levels must be significantly higher than serum levels for proper sperm maturation.
- Estrogen (Estradiol): Elevated estrogen levels can suppress testosterone production and must be regulated.
Medications and Methods Used in Hormone Therapy
Hormonal treatment is tailored according to the patient's baseline hormone levels. Commonly utilized therapeutic agents include:
- Gonadotropins (hCG and rFSH): Mimic endogenous LH and FSH to directly stimulate the testes and boost testosterone production.
- Selective Estrogen Receptor Modulators (SERMs - Clomiphene Citrate): Stimulate the pituitary gland to increase endogenous FSH and LH secretion.
- Aromatase Inhibitors (Anastrozole): Prevent the conversion of testosterone to estrogen, balancing the testosterone-to-estrogen ratio.
Treatment Duration and Timing of Micro-TESE
The spermatogenesis cycle in humans takes approximately 74 days. Consequently, hormone therapy must be maintained continuously for at least 3 to 6 months to allow mature sperm cells to develop. The Micro-TESE procedure is scheduled once hormone levels reach and stabilize at optimal target ranges.
Impact of Hormone Therapy on Micro-TESE Success Rates
Clinical studies demonstrate that hormonal optimization before Micro-TESE significantly improves sperm retrieval rates (SRR). Particularly in patients with borderline hormone levels or hypogonadotropic hypogonadism, this pre-treatment phase is critical for successful assisted reproductive outcomes.